Drug Trial Radar · NCT06972446
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Jun 20, 2025
Primary completion
Feb 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- May 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheumatoid Arthritis (RA). This study currently includes 3 substudies evaluating different treatments in participants with RA. Substudy 1 will evaluate lutikizumab monotherapy (treatment given alone) compared to placebo (looks like the study treatment but contains no medicine). Substudy 2 will evaluate ravagalimab monotherapy compared to placebo and Substudy 3 will evaluate lutikizumab and ravagalimab combination therapy (treatments given together) compared to placebo. Approximately 180 participants who have failed 1 or 2 biologic/targeted synthetic disease-modifying antirheumatic drug (tsDMARD) therapies will be enrolled in the study at approximately 65 sites worldwide. There may be higher treatment burden for participants in this trial compared to their standard of care treatment without participating in this study. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Conditions
- Rheumatoid Arthritis
Interventions
LutikizumabDrug
Subcutaneous (SC) injection
PlaceboDrug
Subcutaneous (SC) injection
RavagalimabDrug
Subcutaneous (SC) injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With an American College of Rheumatology 50% (ACR50) ResponseTime frame: At Week 12
- Number of Participants with Adverse Events (AEs)Time frame: Up to Approximately Week 22
Locations
96 sites in 12 countries. Site status is shown where the registry gives one.
Sun Valley Arthritis Center /ID# 278331
Peoria, Arizona · Recruiting
Arthritis And Rheumatism Associates (Ara) - Jonesboro /ID# 272896
Jonesboro, Arkansas · Recruiting
Private Practice - Dr. David S. Hallegua /ID# 277608
Beverly Hills, California · Recruiting
Advanced Clinical Research Center, LLC dba TriWest Research Associates /ID# 277826
Chula Vista, California · Recruiting
Newport Huntington Medical Group /ID# 272439
Huntington Beach, California · Recruiting
Cohen Medical Centers /ID# 278341
Thousand Oaks, California · Recruiting
The Lundquist Institute /ID# 272481
Torrance, California · Recruiting
Inland Rheumatology and Osteoporosis Medical Group /ID# 272449
Upland, California · Recruiting
Tekton Research - Fort Collins - East Harmony Road /ID# 272472
Fort Collins, Colorado · Recruiting
Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 272298
Avon Park, Florida · Recruiting
Clinical Research Of West Florida - Phase I Unit /ID# 272428
Clearwater, Florida · Recruiting
Finlay Medical Research - Greenacres /ID# 281654
Greenacres City, Florida · Recruiting
Neoclinical Research - Hialeah /ID# 272070
Hialeah, Florida · Recruiting
South Florida Rheumatology /ID# 278339
Hollywood, Florida · Recruiting
Swati Shah, MD Rheumatology /ID# 273624
Jacksonville, Florida · Recruiting
Life Clinical Trials - Colonial Drive - Margate /ID# 272589
Margate, Florida · Recruiting
HMD Research LLC /ID# 272432
Orlando, Florida · Recruiting
Vitalia Research /ID# 272478
Palm Beach Gardens, Florida · Recruiting
Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 272755
Tampa, Florida · Recruiting
Northwestern Medicine - Northwestern Memorial Hospital /ID# 275422
Chicago, Illinois · Recruiting
Deerbrook Medical Associates /ID# 273439
Libertyville, Illinois · Recruiting
Advanced Quality Medical Research /ID# 277824
Orland Park, Illinois · Recruiting
Arnold Arthritis & Rheumatology /ID# 278354
Skokie, Illinois · Recruiting
Willow Rheumatology and Wellness /ID# 272691
Willowbrook, Illinois · Recruiting
Accurate Clinical Research (SMO/Network/Consortium) /ID# 272650
Lake Charles, Louisiana · Recruiting
AA Medical Research Center - Grand Blanc /ID# 272496
Grand Blanc, Michigan · Recruiting
Sahni Rheumatology & Therapy /ID# 278352
West Long Branch, New Jersey · Recruiting
Albuquerque Center For Rheumatology /ID# 272301
Albuquerque, New Mexico · Recruiting
Northwell Health Physician Partners Rheumatology At Great Neck /ID# 275621
Great Neck, New York · Recruiting
Joint And Muscle Research Institute /ID# 277290
Charlotte, North Carolina · Recruiting
DJL Clinical Research - Charlotte /ID# 272387
Charlotte, North Carolina · Recruiting
Paramount Medical Research and Consulting /ID# 272474
Middleburg Heights, Ohio · Recruiting
Altoona Center For Clinical Research /ID# 272479
Duncansville, Pennsylvania · Recruiting
Low Country Rheumatology /ID# 277607
Summerville, South Carolina · Recruiting
West Tennessee Research Institute /ID# 272453
Jackson, Tennessee · Recruiting
Tekton Research - West Gate /ID# 272270
Austin, Texas · Recruiting
Trinity Universal Research Associates - Carrollton /ID# 272577
Carrollton, Texas · Recruiting
Arthritis Care Of Texas /ID# 277961
Corpus Christi, Texas · Recruiting
Arthritis and Rheumatology Research Institute - Frisco /ID# 272299
Frisco, Texas · Recruiting
Accurate Clinical Research - Houston /ID# 272271
Houston, Texas · Recruiting
Showing 40 of 96 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.